Androgel
AndroGel Testosterone Gel Dangers
AndroGel is a topical testosterone gel for use with men who either no longer produce testosterone or produce it in very low amounts. AndroGel 1.62% and AndroGel 1% contain testosterone, which is absorbed through the skin after application.
AndroGel is manufactured by AbbVie Inc. The U.S. Food and Drug Administration (FDA) is investigating the risk of stroke, heart attack, and death in men taking FDA-approved testosterone products.
One recent study reported a two-fold increase in the risk of heart attack among men aged 65 years and older in the first 90 days following the first prescription. Among younger men less than 65 years old with a pre-existing history of heart disease, the study reported a two- to three-fold increased risk of heart attack in the first 90 days following a first prescription.
How Cellino & Barnes Can Help
As a nationally recognized personal injury law firm, Cellino & Barnes is committed to helping our clients win cases. For more than 60 years we have dedicated ourselves to holding irresponsible companies accountable, and we have won over $2 billion in settlements and verdicts for our clients.
If you or a loved one have experienced cardiovascular issues from the use of a low testosterone drug it is important to contact our personal injury law firm. Our experienced and qualified pharmaceutical attorneys are here to help you. Contact or call Cellino & Barnes (800) 888-8888
Dangerous Possible Side Effects of Androgel Prescription Drug Use
- Cardiovascular Events – FDA is investigating the increased risk of heart attack.
- Stroke – FDA is investigating increased risk of stroke.
- Prostate Cancer – Possible increased risk of prostate cancer.
- Blood Clots – Blood clots in the legs.
Androgel Resources
- Official AndroGel Website
- FDA Investigating Risk of Cardiovascular Events 1-31-2014
- AndroGel Side Effects
Androgel Manufacturer Information
- AbbVie Inc. – Abbott